Advancing gastrointestinal health naturally

Our Gastrointestinal ReProgramming (GaRP) product is a microbiome-targeted multi-component dietary supplement that has been designed to address the primary underlying factors associated with gastrointestinal disorders. More >>

Exclusive Global License Agreement with Zoetis

Anatara has signed an exclusive licensing agreement with Zoetis Inc., the leading global animal health company, for the worldwide development, manufacture, distribution and marketing of Detach. More >>

INTERVIEW WITH PROACTIVE INVESTORS

Anatara Lifesciences CEO Steve Lydeamore sat down with Ky Chow at Proactive Investors last month to talk about the healthcare company’s renewed focus on human health, targeting the 11% of Australians affected by irritable bowel syndrome (IBS). Please click here to watch the interview. More >>

Successful Dietary Supplement Proof of Concept Studies

Anatara’s unique Gastrointestinal ReProgramming (GaRP) dietary supplement has been shown to significantly reduce inflammation and protect and maintain gut integrity in recent in vitro studies. More >>

Anatara Lifesciences brings new hope for sufferers of IBS

Anatara has welcomed IBS Awareness Month this April with news that it is developing a new dietary supplement for sufferers of Irritable Bowel Syndrome (IBS) that will help manage the condition and its associated symptoms. More >>